Roche's Q1 Sales Increase Y/Y on Solid Performance of Key Drugs

Swiss pharma giant Roche Holding AG (RHHBY) posted strong growth in the first quarter of 2025. Sales increased 7% year over year to CHF 15.4 billion and were up 6% at constant exchange rates (CER).(Find the latest earnings estimates and surprises on Zacks Earnings Calendar.)The company reports under two divisions — Pharmaceuticals and Diagnostics. All growth rates mentioned below are on a year-over-year basis and at CER.Sales in the Pharmaceuticals Division were up 8% in the first quarter to CHF 11.9 billio ...